Details
Stereochemistry | ACHIRAL |
Molecular Formula | Ag.NO3 |
Molecular Weight | 169.8731 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ag+].[O-][N+]([O-])=O
InChI
InChIKey=SQGYOTSLMSWVJD-UHFFFAOYSA-N
InChI=1S/Ag.NO3/c;2-1(3)4/q+1;-1
DescriptionSources: https://www.purebio.com/assets/001/5202.pdfhttp://google.com/patents/CN102923966Bhttps://www.ncbi.nlm.nih.gov/pubmed/19278981https://www.ncbi.nlm.nih.gov/pubmed/26897901https://www.ncbi.nlm.nih.gov/pubmed/25781988The legal airborne permissible exposure limit (PEL) is 11 mg/m^2 averaged over an 8-hour workshift.https://www.ncbi.nlm.nih.gov/pubmed/20429870https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2930 | https://www.ncbi.nlm.nih.gov/pubmed/11294738Curator's Comment: description was created based on several sources, including
https://www.drugs.com/monograph/silver-nitrate.html |
https://www.ncbi.nlm.nih.gov/pubmed/18245232
Sources: https://www.purebio.com/assets/001/5202.pdfhttp://google.com/patents/CN102923966Bhttps://www.ncbi.nlm.nih.gov/pubmed/19278981https://www.ncbi.nlm.nih.gov/pubmed/26897901https://www.ncbi.nlm.nih.gov/pubmed/25781988The legal airborne permissible exposure limit (PEL) is 11 mg/m^2 averaged over an 8-hour workshift.https://www.ncbi.nlm.nih.gov/pubmed/20429870https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2930 | https://www.ncbi.nlm.nih.gov/pubmed/11294738
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/monograph/silver-nitrate.html |
https://www.ncbi.nlm.nih.gov/pubmed/18245232
Silver iodide is an inorganic compound with the formula AgI. It is used as a photosensitive agent in photography, as a local antiseptic, as a chemical intermediate, and in cloud seeding for rain-making. The major hazards encountered in the use and handling of silver iodide stem from its toxicologic properties. Effects from exposure may include skin rashes, conjunctivitis, argyria (a permanent ashen-gray discoloration of skin, conjunctiva, and internal organs), headache, fever, hypersensitivity, laryngitis, and bronchitis.
Originator
Sources: Vestsi Akademii Navuk BSSR, Seryya Khimichnykh Navuk, Issue 2, Pages 69-73, Journal, 1990https://www.ncbi.nlm.nih.gov/pubmed/20429870
Curator's Comment: The medical uses of silver date back to at least the time of Hippocrates
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0034505 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26897901 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0034505 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24373700 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Advantage Arrest Silver Diamine Fluoride Approved UseUnknown |
|||
Primary | Advantage Arrest Silver Diamine Fluoride Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Primary | Colloidal silver iodide Approved UseSolution containing 5 to 49% of colloidal silver iodide have been employed in the treatment of infections of the mucous membranes. Ointments, usually containing 5%, have been used in inflammatory conditions of the eye, ear, and nose. |
|||
Primary | Colloidal silver iodide Approved UseSolution containing 5 to 49% of colloidal silver iodide have been employed in the treatment of infections of the mucous membranes. Ointments, usually containing 5%, have been used in inflammatory conditions of the eye, ear, and nose. |
|||
Palliative | Unknown Approved UseAntiseptic Wound Cauterization |
|||
Primary | Unknown Approved UseProphylaxis of gonococcal ophthalmia neonatorum. AAP recommends use of topical silver nitrate, povidone-iodine, or possibly erythromycin for prophylaxis of nongonococcal nonchlamydial conjunctivitis in neonates, ideally administered shortly after birth. |
PubMed
Title | Date | PubMed |
---|---|---|
Topical antimicrobials for burn wound infections. | 2010 Jun |
|
Cleaning and decontamination efficacy of wiping cloths and silver dihydrogen citrate on food contact surfaces. | 2012 Jul |
|
A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione. | 2014 Apr 22 |
|
UCSF Protocol for Caries Arrest Using Silver Diamine Fluoride: Rationale, Indications and Consent. | 2016 Jan |
|
An alternate technique of care using silver fluoride followed by stannous fluoride in the management of root caries in aged care. | 2016 Mar-Apr |
|
Directional growth of Ag nanorod from polymeric silver cyanide: A potential substrate for concentration dependent SERS signal enhancement leading to melamine detection. | 2017 Aug 5 |
|
The antifungal effects and mechanical properties of silver bromide/cationic polymer nano-composite-modified Poly-methyl methacrylate-based dental resin. | 2017 May 8 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.purebio.com/assets/001/5202.pdf
Curator's Comment: Toxicity data
Topical as a 1:80 dilution (30 ppm ionic silver).
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27775827
10 mkl volume of undiluted human norovirus 20% faecal suspension was mixed with 90 mkl of SDC (Silver Dihydrogen Citrate) for various contact times (15, 30, 60, 120, 300, 600 and 1800 s). At each sampling time point, 20 mkl of this solution was added to 180 mkl of 10% solution of Dey/Engley (D/E) neutralizing broth (Thermo Fisher Scientific, Waltham, MA). Samples were aliquoted and frozen at -80°C prior to nucleic acid extraction.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
D08AL01
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
||
|
EPA PESTICIDE CODE |
72503
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 296
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
||
|
WHO-VATC |
QD08AL01
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
||
|
WHO-ATC |
S01AX02
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
||
|
CFR |
21 CFR 310.544
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
95IT3W8JZE
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
DTXSID3032042
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
685
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
D012835
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
135800
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
21 CFR 176.300
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
7761-88-8
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
231-853-9
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
DB11080
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
24470
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
SILVER NITRATE
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | Description: Colourless or white crystals or white cylindrical rods; odourless. Solubility: Soluble in 0.5 parts of water; soluble in ethanol (~750 g/l) TS. Category: Antiinfective agent. Storage: Silver nitrate should be kept in a tightly closed, non-metallic container, protected from light. Additional information: Even in the absence of light, Silver nitrate is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. On exposure to light and in the presence of organic matter, it becomes grey or greyish black. Definition: Silver nitrate contains not less than 99.0% and not more than 100.5% of AgNO3. | ||
|
32130
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
C77057
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
m9927
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB15248MIG
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
95IT3W8JZE
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
9789
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | RxNorm | ||
|
4502
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
SILVER NITRATE
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY | |||
|
100000078614
Created by
admin on Fri Dec 15 15:57:46 GMT 2023 , Edited by admin on Fri Dec 15 15:57:46 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD